Furthermore, RBM10 is mutated in pancreatic intraductal papillary mucinous neoplasms [56], 7% of lung adenocarcinomas [57], and 21% of invasive lung adenocarcinomas [21]. Here, RBM10 is linked to lung adenocarcinoma.